Literature DB >> 24458266

Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity.

Bruno B Andrade1, Nathella Pavan Kumar2, Rathinam Sridhar3, Vaithilingam V Banurekha4, Mohideen S Jawahar4, Thomas B Nutman5, Alan Sher5, Subash Babu6.   

Abstract

BACKGROUND: The increased prevalence of type 2 diabetes mellitus (T2DM) in countries endemic for TB poses a serious complication in the clinical management of this major infectious disease. Understanding the impact of T2DM on TB and the determinants of comorbidity is critical in responding to this growing public health problem with better therapeutic approaches. Here, we performed an exploratory study assessing a series of biologic parameters that could serve as markers of pathogenesis in TB with T2DM.
METHODS: Cross-sectional analyses of levels of heme oxygenase-1 (HO-1), acute phase proteins, tissue metalloproteinases, and tissue inhibitors of metalloproteinase (TIMPs) as well as cytokines and chemokines were performed in plasma samples from individuals with active pulmonary TB or with coincident TB and T2DM from South India.
RESULTS: Compared with patients with TB without diabetes, those with coincident T2DM exhibited increased Mycobacterium tuberculosis bacillary loads in sputum. Plasma levels of HO-1 but not of other acute phase proteins were higher in patients with TB and T2DM than in patients without diabetes, independent of bacillary sputum loads. HO-1 concentrations also positively correlated with random plasma glucose, circulating glycosylated hemoglobin, and low-density lipoprotein levels. Moreover, patients with coincident TB and T2DM exhibited increased plasma levels of TIMP-4 and elevated peripheral blood neutrophil counts, which, when considered together with HO-1, resulted in increased power to discriminate individuals with active TB with and without T2DM.
CONCLUSIONS: Elevated plasma levels of HO-1 and TIMP-4 and peripheral blood neutrophil counts are potential single and combined markers of pathogenesis in TB and T2DM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24458266      PMCID: PMC4042512          DOI: 10.1378/chest.13-1799

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  31 in total

Review 1.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

Review 2.  Matrix metalloproteinases in tuberculosis.

Authors:  P T Elkington; C A Ugarte-Gil; J S Friedland
Journal:  Eur Respir J       Date:  2011-06-09       Impact factor: 16.671

Review 3.  Tuberculosis biomarkers discovery: developments, needs, and challenges.

Authors:  Robert S Wallis; Peter Kim; Stewart Cole; Debra Hanna; Bruno B Andrade; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

4.  The Chennai Urban Rural Epidemiology Study (CURES)--study design and methodology (urban component) (CURES-I).

Authors:  M Deepa; R Pradeepa; M Rema; Anjana Mohan; R Deepa; S Shanthirani; V Mohan
Journal:  J Assoc Physicians India       Date:  2003-09

5.  MMP-1 drives immunopathology in human tuberculosis and transgenic mice.

Authors:  Paul Elkington; Takayuki Shiomi; Ronan Breen; Robert K Nuttall; Cesar Augusto Ugarte-Gil; Naomi F Walker; Luísa Saraiva; Bernadette Pedersen; Francesco Mauri; Marc Lipman; Dylan R Edwards; Brian D Robertson; Jeanine D'Armiento; Jon S Friedland
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

6.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

7.  Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection.

Authors:  Bisweswar Nandi; Samuel M Behar
Journal:  J Exp Med       Date:  2011-10-03       Impact factor: 14.307

8.  Impact of diabetes and smoking on mortality in tuberculosis.

Authors:  George W Reed; Hongjo Choi; So Young Lee; Myungsun Lee; Youngran Kim; Hyemi Park; Jongseok Lee; Xin Zhan; Hyeungseok Kang; SooHee Hwang; Matthew Carroll; Ying Cai; Sang-Nae Cho; Clifton E Barry; Laura E Via; Hardy Kornfeld
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

9.  The expression of a nitric oxide derivative, tissue inhibitors of metalloproteinase-3, and tissue inhibitors of metalloproteinase-4 in chronic periodontitis with type 2 diabetes mellitus.

Authors:  Hyun-Yub Jung; Yong-Gun Kim; Jin-Woo Park; Jo-Young Suh; Jae-Mok Lee
Journal:  J Periodontal Implant Sci       Date:  2013-04-30       Impact factor: 2.614

Review 10.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

View more
  25 in total

1.  Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting.

Authors:  Yuri F van der Heijden; Fareed Abdullah; Bruno B Andrade; Jason R Andrews; Devasahayam J Christopher; Julio Croda; Heather Ewing; David W Haas; Mark Hatherill; C Robert Horsburgh; Vidya Mave; Helder I Nakaya; Valeria Rolla; Sudha Srinivasan; Retna Indah Sugiyono; Cesar Ugarte-Gil; Carol Hamilton
Journal:  Tuberculosis (Edinb)       Date:  2018-10-01       Impact factor: 3.131

2.  Heightened Systemic Levels of Neutrophil and Eosinophil Granular Proteins in Pulmonary Tuberculosis and Reversal following Treatment.

Authors:  Kadar Moideen; Nathella Pavan Kumar; Dina Nair; Vaithilingam V Banurekha; Ramalingam Bethunaickan; Subash Babu
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

Review 3.  Influence of diabetes mellitus on immunity to human tuberculosis.

Authors:  Pavan Kumar Nathella; Subash Babu
Journal:  Immunology       Date:  2017-06-29       Impact factor: 7.397

4.  Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Shanmugam Sivakumar; Pradeep A Menon; Vijay Viswanathan; Hardy Kornfeld; Subash Babu
Journal:  J Infect       Date:  2016-10-04       Impact factor: 6.072

Review 5.  Convergence of non-communicable diseases and tuberculosis: a two-way street?

Authors:  M J Magee; A D Salindri; U P Gujral; S C Auld; J Bao; J S Haw; H-H Lin; H Kornfeld
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

6.  Correlates of Vaccine-Induced Protection against Mycobacterium tuberculosis Revealed in Comparative Analyses of Lymphocyte Populations.

Authors:  Sherry L Kurtz; Karen L Elkins
Journal:  Clin Vaccine Immunol       Date:  2015-08-12

7.  Effect of standard tuberculosis treatment on naive, memory and regulatory T-cell homeostasis in tuberculosis-diabetes co-morbidity.

Authors:  Nathella P Kumar; Kadar Moideen; Vijay Viswanathan; Hardy Kornfeld; Subash Babu
Journal:  Immunology       Date:  2016-07-26       Impact factor: 7.397

Review 8.  The Interplay Between Systemic Inflammation, Oxidative Stress, and Tissue Remodeling in Tuberculosis.

Authors:  Eduardo P Amaral; Caian L Vinhaes; Deivide Oliveira-de-Souza; Betania Nogueira; Kevan M Akrami; Bruno B Andrade
Journal:  Antioxid Redox Signal       Date:  2020-06-19       Impact factor: 8.401

9.  Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis - Diabetes co-morbidity.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Vijay Viswanathan; Shanmugam Sivakumar; Syed Hissar; Hardy Kornfeld; Subash Babu
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-04-22

10.  Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies.

Authors:  Mohammad Ali Moni; Pietro Liò
Journal:  BMC Bioinformatics       Date:  2014-10-24       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.